Join Today!

Become a member and connect with:

An Active Online Community
Articles and Advice on SCD
Help Understanding Clinical Trials

healthcare providers

Jeffrey Lebensburger, MD

Healthcare Provider
Associate Professor of Hematology/Oncology
UAB Division of Hematology and Oncology
Children's of Alabama
1600 7th Ave. S.
Lowder Bldg., Suite 512
Birmingham, Alabama, United States

Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children’s Research Hospital. His primary clinical focus involves caring for children with blood disorders, including sickle cell disease, thalassemia, bleeding disorders, disorders of iron metabolism, and marrow failure syndromes.

In addition to his clinical care, Dr. Lebensburger focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. Currently, Dr. Lebensburger is the primary investigator for two prestigious research grants from the National Institutes of Health and American Society of Hematology to better understand kidney disease in patients with sickle cell disease. While pain is the hallmark clinical complication of sickle cell disease, many young adult patients suffer from early development of kidney failure.

Representative Publications:

Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study

Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis

Cranial epidural hematomas: A case series and literature review of this rare complication associated with sickle cell disease

Hydroxycarbamide for patients with silent cerebral infarcts: outcomes and patient preference

Elective cholecystectomy reduces morbidity of cholelithiasis in pediatric sickle cell disease

view full profile